openPR Logo
Press release

Pregabalin Market to Register High Demand Rate Worldwide: Top Manufactures, Challenges And Drivers By 2025 And Key Players Are Lupin, Cipla, Genesis Remedies, Sanofi, Biomax

03-27-2019 03:22 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Pregabalin Market

Pregabalin Market

Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.

Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. According to the Global Year Against Neuropathic Pain 2014-2015 report by International Association of the Study of Pain, around 7%8% of adults suffer from chronic pain with neuropathic characteristics. Furthermore, Pfizers patent expiry of Lyrica (Pregabalin) in 2018 is anticipated to increase the market share of generic manufacturing companies in the UK.

Download Request Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2652

However, stringent government regulations, lack of awareness about neuropathic pain, presence of substitutes of Pregabalin such as gabapentin, and adverse drug effects hinder the market growth. High investment in developing nations are proving new opportunities for the market players.

The Pregabalin market is segmented on the basis of application, end user, and geography. Based on application, the market is divided into epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Based on the end user, it is classified into research institutes, pharmaceutical companies, and others (hospitals and clinics). Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits
• The study provides an in-depth analysis of the global Pregabalin market, with current trends and future estimations to elucidate the investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
• The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments facilitates to understand various products of the market.
• Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

List of players profiled in the report

• Pfizer Inc.
• Torrent Pharmaceuticals Ltd.
• Lupin Limited
• Zydus Cadila Healthcare Ltd.
• Cipla Limited
• Genesis Remedies
• Sanofi
• Medley Pharmaceuticals Limited
• Genesis Biotec Inc.
• Biomax

Send Enquiry Us @ https://www.alliedmarketresearch.com/purchase-enquiry/2652

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pregabalin Market to Register High Demand Rate Worldwide: Top Manufactures, Challenges And Drivers By 2025 And Key Players Are Lupin, Cipla, Genesis Remedies, Sanofi, Biomax here

News-ID: 1673219 • Views: 242

More Releases from Allied Market Research

U.S. Baby Infant Formula Market Insights, Rising Trends and Global Demand From 2 …
According to a new report published by Allied Market Research, titled, U.S. Baby Infant Formula Market by Product Type, Ingredient, Distribution Channel, and Point of Sale (POS): Opportunity Analysis and Industry Forecast, 2021–2027,” the U.S. baby infant formula market size is expected to reach $5,811 million by 2027 at a CAGR of 5.8% from 2021 to 2027. The growth of the U.S. baby infant formula market is majorly driven by rise
Plant-based Meat Market Significant Growth 2021: Industrial Rapid Development by …
Plant-based meat refers to products made from plant materials that are designed to mimic meat in every way, from taste, texture, smell, and appearance. Plant-based meat can come in the form of burgers, sausages, ground meat, crumbles, nuggets, even faux-seafood such as shrimp and fish, and use one, or a combination, of alternative protein ingredients. Download Free Sample Report@ https://www.alliedmarketresearch.com/request-sample/10909 Plant-based Meat Market Report provides an overview of the market based
Overactive Bladder Treatment Market Detailed Analysis of Business Overview, Chal …
Overactive bladder, also called OAB, causes a frequent and sudden urge to urinate that may be difficult to control. Overactive bladder occurs as muscles of the bladder start to contract involuntarily even when the volume of urine in bladder is low. These involuntary contractions create an urgent need to urinate. One may feel the need to pass urine many times during day and night, and may also experience unintentional loss
Nocturnal Polyuria Treatment Market 2021: In-depth Analysis of Industry Players, …
Nocturnal polyuria or nocturia is a condition that causes you to wake up during the night to urinate or increased frequency of having to urinate more often at night. It is important to distinguish nocturia (urinating too frequently) from polyuria (urinating too much volume). This condition becomes more common as people age and occurs in both men and women. It can be common for most people to wake up once

All 5 Releases


More Releases for Pregabalin

Pregabalin Market Is Top Scenario, SWOT Analysis, Business Overview & Forecast 2 …
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body. Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/2652?reqfor=covid The global market size of Pregabalin market is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027
Global Pregabalin market:Potential Segments & their Contribution to Market Size …
The global Pregabalin market is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data on the global Pregabalin market. The report equips players with useful information and suggests result-oriented ideas to gain a competitive edge in the global Pregabalin
Pregabalin Market Demand, Production Growth, Top Key Players and Forecast to 202 …
The report elaborates the complete details covering product definition, product type, and application. The report covers useful details which are categorized based on Pregabalin production region, major players, and product type which will provide a simplified view of the Pregabalin industry. The Pregabalin market report presents the competitive scenario of the major market players based on the sales revenue, customer demands, company profile, the business tactics used in Pregabalin market
Huge Investment in Pregabalin Market Expected to Witness the Highest Growth 2024 …
The growing demand for Pregabalin has provided a major boost to the Global Pregabalin Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2020 up to 2024. Overview of Global Pregabalin Market: Pregabalin, marketed under the brand name Lyrica among others, is a medication
Pregabalin Market Witnessing a Robust Growth With Impressive CAGR During Forecas …
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves a decrease in pain signals sent by the damaged nerves in the body. Increase in a geriatric population suffering from neuropathic diabetes and the rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. Download Sample Report @
Pregabalin Market in-depth analysis with current trends and future estimations 2 …
Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body. Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. According to the Global Year against Neuropathic